These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10188730)

  • 1. GD2-mediated melanoma cell targeting and cytotoxicity of liposome-entrapped fenretinide.
    Pagnan G; Montaldo PG; Pastorino F; Raffaghello L; Kirchmeier M; Allen TM; Ponzoni M
    Int J Cancer; 1999 Apr; 81(2):268-74. PubMed ID: 10188730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo antitumor activity of liposomal Fenretinide targeted to human neuroblastoma.
    Raffaghello L; Pagnan G; Pastorino F; Cosimo E; Brignole C; Marimpietri D; Montaldo PG; Gambini C; Allen TM; Bogenmann E; Ponzoni M
    Int J Cancer; 2003 May; 104(5):559-67. PubMed ID: 12594810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-(4-hydroxyphenyl) retinamide is cytotoxic to melanoma cells in vitro through induction of programmed cell death.
    Montaldo PG; Pagnan G; Pastorino F; Chiesa V; Raffaghello L; Kirchmeier M; Allen TM; Ponzoni M
    Int J Cancer; 1999 Apr; 81(2):262-7. PubMed ID: 10188729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoliposomal fenretinide: a novel antitumoral drug for human neuroblastoma.
    Raffaghello L; Pagnan G; Pastorino F; Cosimo E; Brignole C; Marimpietri D; Bogenmann E; Ponzoni M; Montaldo PG
    Cancer Lett; 2003 Jul; 197(1-2):151-5. PubMed ID: 12880975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenretinide sensitizes multidrug-resistant human neuroblastoma cells to antibody-independent and ch14.18-mediated NK cell cytotoxicity.
    Shibina A; Seidel D; Somanchi SS; Lee DA; Stermann A; Maurer BJ; Lode HN; Reynolds CP; Huebener N
    J Mol Med (Berl); 2013 Apr; 91(4):459-72. PubMed ID: 23052481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
    Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
    Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity of adriamycin-containing immunoliposomes targeted with anti-ganglioside monoclonal antibodies.
    Ohta S; Igarashi S; Honda A; Sato S; Hanai N
    Anticancer Res; 1993; 13(2):331-6. PubMed ID: 8517645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sterically stabilized anti-G(M3), anti-Le(x) immunoliposomes: targeting to B16BL6, HRT-18 cancer cells.
    Nam SM; Kim HS; Ahn WS; Park YS
    Oncol Res; 1999; 11(1):9-16. PubMed ID: 10451027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin-loaded Fab' fragments of anti-disialoganglioside immunoliposomes selectively inhibit the growth and dissemination of human neuroblastoma in nude mice.
    Pastorino F; Brignole C; Marimpietri D; Sapra P; Moase EH; Allen TM; Ponzoni M
    Cancer Res; 2003 Jan; 63(1):86-92. PubMed ID: 12517782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of antibody-dependent cytotoxicity with a chimeric anti-GD2 antibody.
    Mueller BM; Romerdahl CA; Gillies SD; Reisfeld RA
    J Immunol; 1990 Feb; 144(4):1382-6. PubMed ID: 2303711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
    Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M
    Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors.
    Kalinovsky DV; Kibardin AV; Kholodenko IV; Svirshchevskaya EV; Doronin II; Konovalova MV; Grechikhina MV; Rozov FN; Larin SS; Deyev SM; Kholodenko RV
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced anti-tumor and anti-angiogenic efficacy of a novel liposomal fenretinide on human neuroblastoma.
    Di Paolo D; Pastorino F; Zuccari G; Caffa I; Loi M; Marimpietri D; Brignole C; Perri P; Cilli M; Nico B; Ribatti D; Pistoia V; Ponzoni M; Pagnan G
    J Control Release; 2013 Sep; 170(3):445-51. PubMed ID: 23792118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators.
    Batra S; Reynolds CP; Maurer BJ
    Cancer Res; 2004 Aug; 64(15):5415-24. PubMed ID: 15289350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P450 inhibitor ketoconazole increased the intratumor drug levels and antitumor activity of fenretinide in human neuroblastoma xenograft models.
    Lopez-Barcons L; Maurer BJ; Kang MH; Reynolds CP
    Int J Cancer; 2017 Jul; 141(2):405-413. PubMed ID: 28340497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma.
    Lopes de Menezes DE; Pilarski LM; Allen TM
    Cancer Res; 1998 Aug; 58(15):3320-30. PubMed ID: 9699662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy?
    Ohlmann CH; Jung C; Jaques G
    Int J Cancer; 2002 Aug; 100(5):520-6. PubMed ID: 12124800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of N-(4-hydrophenyl) retinamide on liver cancer and malignant melanoma cells.
    Wu XZ; Zhang L; Shi BZ; Hu P
    World J Gastroenterol; 2005 Oct; 11(37):5763-9. PubMed ID: 16270382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism.
    Maurer BJ; Melton L; Billups C; Cabot MC; Reynolds CP
    J Natl Cancer Inst; 2000 Dec; 92(23):1897-909. PubMed ID: 11106681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroblastoma targeting by c-myb-selective antisense oligonucleotides entrapped in anti-GD2 immunoliposome: immune cell-mediated anti-tumor activities.
    Brignole C; Marimpietri D; Pagnan G; Di Paolo D; Zancolli M; Pistoia V; Ponzoni M; Pastorino F
    Cancer Lett; 2005 Oct; 228(1-2):181-6. PubMed ID: 15936140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.